ADAP
Adaptimmune Therapeutics
ADAP
ADAP
71 hedge funds and large institutions have $348M invested in Adaptimmune Therapeutics in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 11 closing their positions.
Holders
71
Holders Change
+4
Holders Change %
+5.97%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
21
Reduced
17
Closed
11
Calls
$158K
Puts
$108K
Net Calls
+$50K
Net Calls Change
-$38K